Portal de investigación
Sinergias en descubrimiento de fármacos en España. ES-OPENSCREEN_2
Datos básicos
- Código Financiador:
- Año inicial:
- 2023
- Año final:
- 2026
Documentos
- No hay documentos
Participantes
Grupos de Investigación
Financiadores
Resultados del Proyecto
A Rapid, Convergent Approach to the Identification of Exosome Inhibitors in Breast Cancer Models.
Andreu Z; (...); Vicent MJ
Article. 10.7150/ntno.73606. 2023
A renal clearable fluorogenic probe for in vivo ß-galactosidase activity detection during aging and senolysis
Rojas-Vázquez, S; (...); Martínez-Máñez, R
Article. 10.1038/s41467-024-44903-1. 2024
An Offset Patterned Cross-ß Structure in Assemblies of C 3 -Symmetric Peptide Amphiphiles.
Zagorodko O; (...); Vicent MJ
Article. 10.1002/chem.202303194. 2024
Comparative profiling of whole-cell and exosome samples reveals protein signatures that stratify breast cancer subtypes.
Andreu Z; (...); Vicent MJ
Article. 10.1007/s00018-024-05403-z. 2024
Critical Design Strategies Supporting Optimized Drug Release from Polymer-Drug Conjugates.
Ðordevic S; (...); Vicent MJ
Article. 10.1002/smll.202303157. 2023
Exploring the neuroprotective potential of antimicrobial peptides from Dinoponera quadriceps venom against pentylenetetrazole-induced seizures in vivo.
Paes LCF; (...); Martins AMC
Article. 10.1016/j.toxicon.2023.107538. 2024
High-Capacity Mesoporous Silica Nanocarriers of siRNA for Applications in Retinal Delivery.
Ultimo A; (...); Ruiz-Hernández E
Article. 10.3390/ijms24032753. 2023
Morphology evolution of supramolecular aggregates from C3-symmetric peptide amphiphiles
Zagorodko, O, Melnyk, T, Vicent, MJ
Article. 10.1016/j.molliq.2024.125664. 2024
NMR-Based Mitochondria Metabolomic Profiling: A New Approach To Reveal Cancer-Associated Alterations.
Domingo-Ortí I; (...); Palomino-Schätzlein M
Article. 10.1021/acs.analchem.3c02432. 2023
Phenotyping of cancer-associated somatic mutations in the BCL2 transmembrane domain
Leiva, D; (...); Orzáez, M
Article. 10.1038/s41389-024-00516-3. 2024
Poly-l-glutamic acid modification modulates the bio-nano interface of a therapeutic anti-IGF-1R antibody in prostate cancer.
Vicente-Ruiz S; (...); Vicent MJ
Article. 10.1016/j.biomaterials.2023.122280. 2023
Rational design of poly-L-glutamic acid-palbociclib conjugates for pediatric glioma treatment.
Melnyk T; (...); Vicent MJ
Article. 10.1016/j.jconrel.2023.01.079. 2023
Targeted Delivery of the Pan-Inflammasome Inhibitor MM01 as an Alternative Approach to Acute Lung Injury Therapy.
García-Fernández A; (...); Orzáez M
Article. 10.1002/adhm.202301577. 2023
Unlocking the Mitochondria for Nanomedicine-based Treatments: Overcoming Biological Barriers, Improving Designs, and Selecting Verification Techniques.
Pegoraro C; (...); Vicent MJ
Article. 10.1016/j.addr.2024.115195. 2024